AlicePChenMD

PubMed

• Phase II Study of Osimertinib in Patients With Epidermal Growth Factor Receptor Mutations: Results From the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E.
  Monica F Chen, Zihe Song, Helena A Yu, Lecia V Sequist, Christine M Lovly, Edith P Mitchell, Jeffrey A Moscow, Robert J Gray, Victoria Wang, Lisa M McShane, Larry V Ru...> ;JCO Precision Oncology. 2024 Apr 1
• Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J.
  Roisin M Connolly, Victoria Wang, David M Hyman, Petros Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert J Gray, Lisa M McShane, Larry V Rubinstein, David ...> ;Clinical Cancer Research. 2024 Apr 1
• Challenges and Future Directions in the Management of Tumor Mutational Burden-High (TMB-H) Advanced Solid Malignancies.
  Das, B., Shin, S., Ahmed, J., Chen, A.> ;Cancers. 2023 Dec 14
• Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors.
  Arjun Mittra, Geraldine H O' Sullivan Coyne, Jennifer Zlott, Shivaani Kummar, Robert Meehan, Lawrence Rubinstein, Lamin Juwara, Deborah Wilsker, Jiuping Ji, Brandon Mi...> ;Cancer Chemotherapy and Pharmacology. 2024 Mar 1
• 1 citations
  A pilot study of volumetric and density tumor analysis of ACC patients treated with vorinostat in a phase II clinical trial.
  Molly Malarkey, Alex P Toscano, Mohammad Hadi Bagheri, Jeffrey Solomon, Laura B Machado, Patricia LoRusso, Alice Chen, Les R Folio, Priscila H Goncalves> ;Heliyon. 2023 Aug 1
• 12 citations
  The NCI-MATCH trial: lessons for precision oncology.
  Peter J O'Dwyer, Robert J Gray, Keith T Flaherty, Alice P Chen, Shuli Li, Victoria Wang, Lisa M McShane, David R Patton, James V Tricoli, P Mickey Williams, A John Iaf...> ;Nature Medicine. 2023 Jun 1
• NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors.
  Michael Cecchini, Zenta Walther, Wei Wei, Navid Hafez, Mary Jo Pilat, Scott A Boerner, Diane E Durecki, Joseph P Eder, Kurt A Schalper, Alice P Chen, Patricia LoRusso> ;Cancer Research Communications. 2023 Jun 1
• 2 citations
  Rethinking Oncologic Treatment Strategies with Interleukin-2.
  Brian Ko, Naoko Takebe, Omozusi Andrews, Monish Ram Makena, Alice P Chen> ;Cells. 2023 May 5
• 2 citations
  Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B.
  Clark, A., Hong, F., Finn, R., DeMichele, A., Mitchell, E., Zwiebel, J., Arnaldez, F., Gray, R., Wang, V., McShane, L., Rubinstein, L., Patton, D., Williams, P., Hamil...> ;Clinical Cancer Research. 2023 Apr 14
• 5 citations
  Trametinib in Patients With,, or-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2.
  Kari B Wisinski, Yael Flamand, Melissa A Wilson, Jason J Luke, Hussein A Tawbi, Fangxin Hong, Edith P Mitchell, James A Zwiebel, Helen Chen, Robert J Gray, Shuli Li, L...> ;JCO Precision Oncology. 2023 Apr 1
• A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer...
  Monica K Malhotra, Shalu Pahuja, Brian F Kiesel, Leonard J Appleman, Fei Ding, Yan Lin, Hussein A Tawbi, Ronald G Stoller, James J Lee, Chandra P Belani, Alice P Chen,...> ;Breast Cancer Research and Treatment. 2023 Apr 1
• 1 citations
  Evaluating the indotecan-neutropenia relationship in patients with solid tumors by population pharmacokinetic modeling and sigmoidal Eregressions.
  Jan H Beumer, Benjamin C Kennard, Julianne L Holleran, Nancy Moore, Jennifer Zlott, Brian M Miller, Shivaani Kummar, Alice Chen, James Doroshow, Wansu Park, Jogarao Go...> ;Cancer Chemotherapy and Pharmacology. 2023 Mar 1
• 4 citations
  Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma.
  James Nguyen, Naoko Takebe, Shivaani Kummar, Albiruni Razak, Sant P Chawla, Suzanne George, Shreyaskumar R Patel, Mary Louise Keohan, Sujana Movva, Geraldine O'Sulliva...> ;Clinical Cancer Research. 2023 Apr 3
• 2 citations
  Performances of Functional and Anatomic Imaging Modalities inRelated Metastatic Pheochromocytoma and Paraganglioma.
  Mayank Patel, Abhishek Jha, Alexander Ling, Clara C Chen, Corina Millo, Mickey J M Kuo, Matthew A Nazari, Sara Talvacchio, Kailah Charles, Markku Miettinen, Jaydira De...> ;Cancers. 2022 Aug 11
• 5 citations
  Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molec...
  Philippe L Bedard, Shuli Li, Kari B Wisinski, Eddy S Yang, Sewanti A Limaye, Edith P Mitchell, James A Zwiebel, Jeffrey A Moscow, Robert J Gray, Victoria Wang, Lisa M ...> ;JCO Precision Oncology. 2022 Jul 1
• 21 citations
  Phase II Study of Copanlisib in Patients With Tumors WithMutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F.
  Senthil Damodaran, Fengmin Zhao, Dustin A Deming, Edith P Mitchell, John J Wright, Robert J Gray, Victoria Wang, Lisa M McShane, Larry V Rubinstein, David R Patton, P ...> ;Journal of Clinical Oncology. 2022 May 10
• 5 citations
  A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovari...
  Julia Manzo, Shannon Puhalla, Shalu Pahuja, Fei Ding, Yan Lin, Leonard Appleman, Hussein Tawbi, Ronald Stoller, James J Lee, Brenda Diergaarde, Brian F Kiesel, Jing Yu...> ;Cancer Chemotherapy and Pharmacology. 2022 May 1
• 13 citations
  Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.
  A S Mansfield, Z Wei, R Mehra, A T Shaw, C H Lieu, P M Forde, A E Drilon, E P Mitchell, J J Wright, N Takebe, E Sharon, D Hovelson, S Tomlins, J Zeng, K Poorman, N Mal...> ;NPJ Precision Oncology. 2022 Mar 1
• 9 citations
  Phase II Study of Taselisib in-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.
  Ian E Krop, Opeyemi A Jegede, Juneko E Grilley-Olson, Josh D Lauring, Edith P Mitchell, James A Zwiebel, Robert J Gray, Victoria Wang, Lisa M McShane, Larry V Rubinste...> ;JCO Precision Oncology. 2022 Feb 1
• 10 citations
  PARP Inhibitor Applicability: Detailed Assays for Homologous Recombination Repair Pathway Components.
  Geraldine O'Sullivan Coyne, Chris Karlovich, Deborah Wilsker, Andrea Regier Voth, Ralph E Parchment, Alice P Chen, James H Doroshow> ;Oncotargets and Therapy. 2022 Jan 1
• 5 citations
  Clinical activity of single-agent cabozantinib (XL184), a multi-receptor tyrosine kinase inhibitor, in patients with refractory soft tissue sarcomas.
  Geraldine O'Sullivan Coyne, S. Kummar, James C. Hu, Kristen N. Ganjoo, Warren A. Chow, Khanh T. Do, Jennifer Zlott, Ashley Bruns, Larry Rubinstein, Jared C. Foster, La...> ;Clinical Cancer Research. 2021 Oct 29
• 1 citations
  A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies
  Antoinette R. Tan, Nancy Chan, Brian F. Kiesel, Mark N. Stein, Rebecca A. Moss, Jyoti Malhotra, Joseph Aisner, Mansi Shah, Murugesan Gounder, Hongxia Lin, Michael P. K...> ;Cancer Chemotherapy and Pharmacology. 2021 Oct 20
• 8 citations
  Sporadic Primary Pheochromocytoma: A Prospective Intra-Individual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA)
  Abhishek Jha, Mayank Patel, Jorge A. Carrasquillo, Alexander Ling, Corina Millo, Babak Saboury, Clara C. Chen, Paul Wakim, Melissa K Gonzales, Leah Meuter, Marianne Kn...> ;AJR. American Journal of Roentgenology. 2021 Aug 25
• 16 citations
  Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute.
  Arjun Mittra, Abdul Rafeh Naqash, James H Murray, Shanda Finnigan, Joanne Kwak-Kim, S. Percy Ivy, Alice P. Chen, Elad Sharon> ;The Oncologist. 2021 Aug 16
• 11 citations
  Advances in the management of alveolar soft part sarcoma.
  Geraldine O'Sullivan Coyne, Abdul Rafeh Naqash, Hari Sankaran, Alice P. Chen> ;Current Problems in Cancer. 2021 Aug 1
• Join now to see all

Journal Articles

• Effect of Capivasertib in Patients with an AKT1 E17K-Mutated Tumor  
  Kevin Kalinsky, Edith P Mitchell, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Alice P Chen, Keith T Flaherty, JAMA Oncology